EVIDENCE FOR INHIBITION BY ICS-205-930 AND STIMULATION BY BRL-34915 OF K+ CONDUCTANCE IN CARDIAC-MUSCLE

被引：56
作者：
SCHOLTYSIK, G
机构：
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1987年 / 335卷 / 06期
关键词：
D O I：
10.1007/BF00166988
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：692 / 696
页数：5
相关论文
共 26 条
[1]   POTASSIUM CHANNEL BLOCKADE - A MECHANISM FOR SUPPRESSING VENTRICULAR-FIBRILLATION [J].
BACANER, MB ;
CLAY, JR ;
SHRIER, A ;
BROCHU, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (07) :2223-2227
[2]   DRUGS WITH A CLASS III ANTI-ARRHYTHMIC ACTION [J].
BEXTON, RS ;
CAMM, AJ .
PHARMACOLOGY & THERAPEUTICS, 1982, 17 (03) :315-355
[3]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[4]   DIFFERENTIAL ELECTROPHYSIOLOGIC EFFECTS OF MEXILETINE ON NORMAL AND HYPOXIC CANINE PURKINJE-FIBERS [J].
BURKE, GH ;
BERMAN, ND .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (06) :1096-1100
[5]  
CAIN C R, 1985, Naunyn-Schmiedeberg's Archives of Pharmacology, V329, pR53
[6]  
CARMELIET E, 1985, J PHARMACOL EXP THER, V232, P817
[7]   THE EFFECTS OF ICS 205-930, A 5-HT ANTAGONIST, ON ARRHYTHMIAS AND CATECHOLAMINE RELEASE DURING CANINE MYOCARDIAL-ISCHEMIA AND REPERFUSION [J].
COKER, SJ ;
DEAN, HG ;
KANE, KA ;
PARRATT, JR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 127 (03) :211-218
[8]   COMPARISON OF THE EFFECTS OF BRL-34915 AND VERAPAMIL ON ELECTRICAL AND MECHANICAL-ACTIVITY IN RAT PORTAL-VEIN [J].
HAMILTON, TC ;
WEIR, SW ;
WESTON, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (01) :103-111
[9]  
IMANISHI S, 1983, J PHARMACOL EXP THER, V225, P198
[10]   AN INVESTIGATION INTO THE CHARACTERISTICS OF REPERFUSION-INDUCED ARRHYTHMIAS IN THE ANESTHETIZED RAT AND THEIR SUSCEPTIBILITY TO ANTIARRHYTHMIC AGENTS [J].
KANE, KA ;
PARRATT, JR ;
WILLIAMS, FM .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 82 (02) :349-357
123